Cestem flavoured tablets for medium and small dogs
Cestem flavoured tablets for medium and small dogs
Not authorised
- Febantel
- Praziquantel
- Pyrantel embonate
Product identification
Medicine name:
Cestem flavoured tablets for medium and small dogs
Active substance:
- Febantel
- Praziquantel
- Pyrantel embonate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Febantel150.00/milligram(s)1.00Tablet
-
Praziquantel50.00/milligram(s)1.00Tablet
-
Pyrantel embonate50.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Belgium
Package description:
- Polyamide-aluminium-PVC / aluminium blister packs. Box containing 1 blister of 8 tablets.
- Polyamide-aluminium-PVC / aluminium blister packs. Box containing 2 blisters of 2 tablets.
- Polyamide-aluminium-PVC / aluminium blister packs. Box containing 13 blisters of 8 tablets.
- Polyamide-aluminium-PVC / aluminium blister packs. Box containing 1 blister of 2 tablets.
- Polyamide-aluminium-PVC / aluminium blister packs. Box containing 52 blisters of 2 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva Sante Animale
- Ceva Sante Animale
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V372041
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0269/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
